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Abstract
Background: The specification of vein and the patterning of intersegmental vessels (ISV) controlled by transcription
factor is not fully characterized. The orphan nuclear receptor Chicken ovalbumin upstream promoter transcription
factor II (CoupTFII, a.k.a NR2F2) positively regulates vein identity in mice. In this study, we show that nr2f1b is
important for vein and tip cell identity during zebrafish development.
Results: Nr2f1b mRNA is expressed in ventral lateral mesoderm at 15S stage and in vessels at 24 hpf
consistent with a role in early vascular specification. Morpholino knockdown of nr2f1b results in a decrease in
both vein cell number and expression of the vein specific marker flt4 and mrc1, suggested its role in venous
specification. We also show loss of nr2f1b reduced ISV cell number and impairs ISV growth, which is likely
due to the impairment of angiogenic cells migration and/or proliferation by time-lapse imaging.
Consequently, nr2f1b morphants showed pericardial edema and circulation defects. Overexpression of nr2f1b
under the fli promoter increases the number of venous cells and ISV endothelial cells indicated the function
of nr2f1b is required and necessary for vascular development. We further showed that nr2f1b likely interact
with Notch signalling. nr2f1b expression is increased in rbpsuh morphants and DAPT-treatment embryos
suggested nr2f1b is negatively regulated by Notch activity.
Conclusions: We show nr2f1b control venous specification and angiogenic patterning during zebrafish
vascular development, which is mediated by Notch signalings.
Keywords: Nr2f1b, Angiogenesis, vein and tip cell identity, ISV (intersegmental vessel)
Background
Vasculogenesis and angiogenesis are two processes to
establish the pattern of blood vessels network in ver-
tebrates [1, 2]. In the developing zebrafish trunk, a
stereotypic pattern of vascular development begins
with dorsal aorta (DA) and posterior cardinal vein
(PCV) formation at the midline by fusion of angio-
blast progenitors migrating from the lateral posterior
mesoderm by the 17 somite (17S) stage [3]. Develop-
ment of the intersegmental vessels (ISVs) of the trunk
begins with an angioblast sprouting from the DA,
proliferating and migrating dorsally until it reaches
the dorsal aspect of the embryo and connects with
adjacent ISV cells to form the dorsal longitudinal
anastomotic vessels (DLAVs). The leading cells to mi-
grate from the vessel are called tip cells, are prolifera-
tive and show multiple filopodia, while the less
proliferative, stationary cells which lumenize behind
the tip cell are called stalk cells [4, 5].
Many genes and signal pathways have been identified
that regulate the specification and maintenance of arter-
ial identity during vasculogenesis, such as vascular endo-
thelial growth factor (VEGF), nrp1, delta-like 4 (dll4),
gridlock, foxc1 and foxc2 (reviewed in [6, 7]), Signalling
through the Notch receptor is a major contributor to ar-
terial identity as loss of Notch leads to a decrease in the
number of cells expressing arterial markers and an
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increase in cells expressing venous markers [5]. While a
number of signaling molecules have been identified to
promote arterial identify, there is less description about
transcription factors that promote a venous identity. In
mice study, the orphan nuclear receptor NR2F2 is
expressed in venous endothelial cells [8–10]. Loss of
NR2F2 in mouse results in ectopic expression of arterial
markers in the vein with loss of the venous endothelial
cell identity and acquisition of arterial phenotypes. Thus,
NR2F2 functions as the key regulator of venous identity
[9]. Recent studies in zebrafish and xenopus showed that
nr2f2 and SoxF regulated venous differentiation [11, 12].
During the development of intersegmental vessel (ISV)
sprouts from the dorsal aorta, angioblasts will specify two
cell identities, the migratory tip cell that senses attractive
and repulsive through the extension of filopodia, or the
stalk cell that lumenizes to form an intersegmental vessels
(ISVs) [13–15]. ISV angiogenesis has been shown that reg-
ulated by VEGF and Notch-flt4 (Fms-related tyrosine kin-
ase 4) signalings. Knockdown of VEGFR2 disrupt ISV
formation and loss of Notch signaling results in a signifi-
cant increase ISV cells and increase in Flt4 expression [5].
Conversely, loss of Vegfc or Flt4 impaired ISV growth and
a decreased number of angioblasts in each ISV [16].
Moreover, activation of Notch signaling also results in
stalled ISV growth mid-somite, suggesting that Notch re-
presses the Vegfc-Flt4 signaling cascade [17]. In recent
years, many molecules, such as cxcr4, UNC5B, angio-
motin, pdgfb and trpc1 have been shown involved in
angiogenesis [16, 18–21]. Thus, genetic interaction and
coordination contributes to the control of endothelial tip-
stalk cell behaviors during angiogenesis. Of those factors,
NR2F2 in mice has been shown function in angiogen-
esis mediated by the upregulation of Angiopoietin-1 in
addition to its role in venous differentiation [8]. However,
we still have limited knowledge of the role of transcription
factors in tip cell specification. Surprisingly, nr2f2, which
plays a major role in venous specification in mice, acts
only a minor role in zebrafish vascular development based
on our study and recent publications ([11, 12] and our un-
published results).
During the vascular development in mouse, NR2F2
acts as a major regulator in venous identity and in an-
giogenic growth [8, 9]. In addition, Nr2f2 interacts with
Prox1 physically to specific lymphatic endothelial fate
and promote the formation of lymphatic vessels [22, 23].
Our previous study in zebrafish showed that nr2f2 in
zebrafish plays a minor role in venous identity and ISV
growth but functions critically in lymphogenesis, similar
to recent reports. On the other hand, the related tran-
scription factor NR2F1 is a critical regulator of CNS and
peripheral nervous system development and controls cell
differentiation in the inner ear [24–26]. However, a vas-
cular function of NR2F1 has not yet been documented.
In this study, we hypothesized that nr2f1b has a critical
role in blood vessel formation in zebrafish. We showed
that loss of nr2f1b reduced venous cells and the expres-
sion of vein specific markers. We also showed that nr2f1b
morphant reduces ISV cells and impairs ISV growth.
While overexpression of nr2f1b, we observed the increase
of vein and ISV cells, suggesting that nr2f1b play a role in
promoting vein and tip cell identity. We further showed
that nr2f1b functions in vascular development mediated
by Notch signalling.
Methods
Zebrafish strains and husbandry
Zebrafish (Danio rerio) wild-type Tupfel Long Fin (TL) or
transgenic lines: Tg(kdrl:eGFP) la116, Tg(kdrl:mCherry)ci5,
Tg(gata:dsRed), Tg(fli1a:egfp)y1 and Tg(fli1a:negfp)y7 have
been described [27–30]. Zebrafish were raised and main-
tained at the 28.5 °C fish room in a 20 L circulating system
with filtered fresh water and aeration under the 14 hr: 10
hr (light: dark) lighting conditions. Zebrafish embryos
were raised in E3 embryo media (5 mM NaCl, 0.17 mM
KCl, 0.33 mM CaCl2, 0.33 mM MgSO4 and supplemented
with 0.25 mg/L methylene blue) at 28.5 °C according to
the Zebrafish Book [31]. Embryo development and stages
were measured in hour post-fertilization (hpf). Chorions
were removed by incubation in 20 mg/ml pronase (Sigma)
and endogenous pigmentation was blocked by adding
0.003 % N-phenylthiourea (PTU; Sigma) to E3 media at
6 hpf. All animal experiments are approved from the
National Sun Yat-sen University Animal Care Commit-
tee (approval reference #10109)
Whole-mount in situ hybridization
Whole-mount in situ hybridization was performed as
described in [32]. nr2f1b probe template was amplified
by PCR using primers described in Additional file 1:
Table S1 and in vitro transcription using T7 Polymerase
(Roche) with DIG-labeled UTP. The flt4, mrc1, notch3
and ephrinb2 probes have been described [33–35].
Whole-mount in situ hybridization (WISH) was per-
formed as previously described [35, 36]. Briefly, Embryos
were fixed in 4 % paraformaldehyde in phosphate buff-
ered saline (PBS), permeabilized in 10 μg/mL Proteinase
K, hybridized with DIG-labeled probes, washed, reacted
with AP-conjugated anti-Dig antibody (Roche) and then
proceeded to react with NBT/BCIP substrate (Roche).
The reaction was stopped and embryos were fixed with
PFA. Embryos were embedded in 3 % methylcellulose
(Sigma) and photographed.
Imaging
Fixed embryos or live embryos were embedded in 3 %
methylcellulose or 1.5 % low melt agarose (Invitrogen)
and photographed with a Zeiss Axiocam HRc camera
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(Carl Zeiss) on a Zeiss Lumar V12 stereomicroscope.
Confocal images were collected on a Zeiss LSM510 or
LSM700 microscope, and stacked images generated by
ImageJ or ZEN 2012 software (Carl Zeiss). The number
of cells in the vein and ISVs was determined by counting
from individual slices of confocal stacks. The counting
area is between 5th and 15th ISVs of the embryo.
For histology, embryos were sectioned at 5-7 μM in
JB-4 plastic medium (Polysciences, Warrington, PA) and
photographed with a Magnafire camera (Optronics,
Galeta, CA). Alternatively, embryos were fixed with Tek
OCT freezing medium and cryo-sectioned at 10 μM
using a Leica CM3050S cryostat and photographed with
an SPOT RT3 camera (DIAGNOSTIC Inc.).
Morpholino and Tol2 DNA Injections
Morpholinos for nr2f1b and rbpsuh genes were designed
and ordered from Gene-Tools, LLC (Philomath, OR),
dissolved in H2O to a 2 mM stock and further diluted to
the working concentration with 0.5 % phenol red
(Sigma). Sequences are listed in Additional file 1: Table
S1. Microinjections were performed to manipulate gene
expression. MOs or expression vectors were injected
into 1-2-cell-stage embryos on a 3 % agar plate. After in-
jection, embryos were cultured in E3 buffer. The Tol2kit
was used to generate nr2f1b overexpression driven by
0.8kb fli1a promoter construct [37]. Approximately 100
pg of plasmid DNA was co-injected with 50 pg of Tol2
mRNA into 1-cell embryos. Success of transient
Tg(fli1:nr2f1b) overexpressing embryos can be verified by
GFP signal expression driven by cmlc (cardiomyocyte
light chain) promoter from the vector backbone.
RNA extraction, cDNA synthesis and Quantitative RT-PCR
(qPCR)
Total RNA was extracted from embryos at desired develop-
mental stages and purified using the Qiagen RNeasy Mini
Kit (Qiagen) according to the manufacturer’s instructions.
Complementary DNA (cDNA) was synthesized with
Superscript III reverse transcriptase and oligo-dT primer
(Invitrogen) according to the manufacturer’s instructions.
Quantitative RT-PCR was performed using the DNA En-
gine Opticon System (MJ Research Inc.) with iQ SYBR
Green Supermix (BioRad) or using the LightCycle 96 in-
strument (Roche Inc.) with SYBR Green I Master (Roche).
qPCR primers are listed in Additional file 1: Table S1. Rela-
tive gene expression levels were analyzed by the ΔΔ Ct
method, with elongation factor 1α (EF1α) as a reference
gene All reactions were performed as biological triplicates.
DAPT (N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine
t-butyl ester) treatment
Embryos were treated with DAPT (Sigma), γ-secretase
specific inhibitor to block Notch signalling, 75 μM for
the working concentration in E3 medium at 6 hpf.
Control embryos were treated with an equivalent con-
centration 0.3 % of DMSO (Dimethyl sulfoxide, Sigma).
Results
nr2f1b mRNA is expressed in vessels during zebrafish
development
We sought to understand the role of the orphan nuclear re-
ceptors in venous angioblast development. Loss of NR2F2
in mouse leads to an almost complete loss of the cardinal
vein, however, morpholino knockdown of nr2f2 in zebrafish
leads to only a reduction in venous marker expression with-
out obvious defects in vein and ISVs ([11, 12] and our
unpublished result). Since nuclear receptors subfamily 2
group f members (NR2F2) in mammalian and vertebrates
are highly conserved, we hypothesized that nr2f1b in zebra-
fish might play an important role in vasculature.
To examine the role of nr2f1b in vascular development,
we first analyze the expression of nr2f1b by whole-mount
in situ hybridization during zebrafish development. At the
15 somite stage (S), nr2f1b is expressed in the telenceph-
alon (t), ventral medial diencephalon (d), hindbrain rhom-
bomeres (h) and lateral plate mesoderm (Fig. 1a). The
lateral plate mesoderm is the location of vascular precur-
sors. At 20 hpf (~24S), we observed that nr2f1b is
expressed in the vessels (Fig. 1b). At 24 hpf, nr2f1b is
expressed in the telencephalon, diencephalon, hindbrain,
as well as vessels of the trunk and caudal vein plexus
(CVP) (Fig. 1c, c’). Transverse sections of embryos con-
firm this localization (Fig. 1d, e). The expression of nr2f1b
in vasculature during embryonic development and sug-
gests that it may play an important role.
Morpholino knockdown of nr2f1b causes vascular defects
To identify a functional role of nr2f1b in vascular develop-
ment, we used transgentic fish Tg(kdrl:eGFP) la116 which
express GFP in endothelial cells [29] and morpholino-
based knockdown technique. We knocked down the
expression of nr2f1b in embryos by injection of 3 ng of
morpholino targeted against the intron 1-exon 2 splice
junction (nr2f1bi1e2 MO), which showed two major vascu-
lar phenotypes. First, impairment of ISV growth is ob-
served in nr2f1bi1e2 morphants at 30 hpf, where ISV
growth is stalled at mid-somite and ISV pattern is not
completed (Fig. 2b) with 89 % of ISVs (n = 400 ISVs from
40 embryos) compared to 7 % of ISVs stalled in uninjected
controls (n = 260 ISVs from 26 embryos). The second
phenotype we observe is decreased levels of kdrl:GFP
transgene expression in the posterior cardinal vein (PCV)
as compared to uninjected controls at 30 hpf (Fig. 2b).
Two additional morpholinos targeting either the transla-
tion initiation site (nr2f1bATG MO) or the exon 1-intron 1
splice junction (nr2f1be1i1 MO) result in nearly identical
phenotypes (Fig. 2e, f ), providing evidence for the
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specificity of the morpholino knockdown. To further con-
firm the specificity of our morpholino experiments, we
performed rescue experiments by overexpression of
nr2f1b in wild-type and nr2f1bi1e2 morphant embryos.
Transient transgenic overexpression of nr2f1b in endothe-
lial cells under the fli1 promoter rescues ISV stalling by 40
% in nr2f1b morphants (n = 220 from 22 embryos) com-
pared to injection of nr2f1b morpholino alone (Fig. 2c, g),
while overexpression of nr2f1b in wild-type embryos has
no obvious defect on vascular development (Fig. 2d, n =
250 from 25 embryos).
We tested the efficiency and specificity of nr2f1bi1e2
morpholino knockdown. Injection of 1.7 ng or 3 ng of
nr2f1bi1e2 morpholino showed dose-dependent disrup-
tion of normal splicing of nr2f1b as determined by RT-
PCR (Additional file 1: Figure S1A, B), suggesting the
efficiency of nr2f1b knockdown. Sequence comparison
of nr2f1bi1e2 morpholino targeting to nr2f1a and nr2f2
showed only 52 % and 28 % identity, respectively. More-
over, injection of nr2f1bi1e2 morpholino greatly decrease
the amount of the nr2f1b product, but nr2f1a and nr2f2
levels were not decreased compared to uninjected con-
trols as determined by RT-PCR, indicating the specificity
of the morpholino knockdown of nr2f1b (Additional
file 1: Figure S1C, D).
Further, nr2f1b morphant phenotypes do not result
from morpholino-induced non-specific cell death as
there is no significant increase in apoptosis in the trunk
of morphants compared to wild type embryos by
TUNEL staining (Additional file 1: Figure S2). These re-
sults suggested the phenotypes of stalled ISV growth and
decreased venous kdrl transgene expression are specific
to the down-regulation of nr2f1b and indicate that
nr2f1b plays a key role in zebrafish vascular develop-
ment. To test if loss of nr2f1b would decrease cell prolif-
eration, we counted the numbers of endothelial cells per
ISV in the Tg (kdrl:mCherryci5; fli1a:negfp y7) embryos,
where GFP was expressed in the nucleus of endothelial
cells and the mCherry tag in the cytoplasm. Loss of
nr2f1b showed significantly reduced ISV cell numbers
compared to uninjected wild type embryos (1.8 ± 0.8
cells per ISV, n = 107 ISV from 18 embryos of nr2f1b
morphants and 3.8 ± 0.8 cells, n = 108 ISV from 16 wt
embryo, p < 0.0001) (Fig. 2 H-J). These data suggest that
nr2f1b is required for ISV cell growth to contribute to
the vascular development, likely by regulation of the
proliferation or migration of the cells. Finally, a third
phenotype was observed that loss of nr2f1b results in
pericardial edema, absent parachordal vessels, mispat-
terned subintestinal vessel plexus and circulation defects
at later stages from 48 hpf to 72 hpf (Additional file 1:
Figure S3). Since edema and lack of circulation are com-
mon secondary consequences of defective blood vessel
formation. The circulation defects consistent with the
role of nr2f1b in vascular development.
Nr2f1b promotes vein identity
Reduced kdrl-transgene expression in the PCV of nr2f1b
morphant embryos could result from decreased number
of cells contributing to the PCV or decreased venous
endothelial marker expression of resident endothelial
cells. Thus, we analyzed whether the number of endo-
thelial cells is reduced in the PCV in nr2f1b morphants
by using Tg(fli1a:neGFP)y7 embryos which expressing
GFP in endothelial cell nuclei and counting venous cells
in the PCV in the region of the yolk extension (i. e. be-
tween 5th to 15th ISVs) at 30 hpf. Uninjected control
embryos have an average of 82.5 ± 11.5 cells (n = 14 em-
bryos) in this region while nr2f1bi1e2 morphants have a
significantly decreased number of cells with an average
of 61.8 ± 14.7 cells (n = 12 embryos; p < 0.0001; Fig. 3a-c).
Decreased PCV cell number suggests that loss of nr2f1b
leads to a defect in the specification of venous cells con-
tributing to the PCV but without a fate switch to an
Fig. 1 Expression of nr2f1b in during zebrafish development. a At 15S,
nr2f1b is expressed in the telencephalon (t), ventral medial diencephalon
(d), hindbrain rhombomeres (h) and lateral plate mesoderm (lpm, arrow)
corresponding in location to the developing vasculature. At 20hpf
(~24S), nr2f1b is expressed in the vessels (b). c, c' At 24 hpf, nr2f1b is
expressed in the telencephalon (t), diencephalon (d), hindbrain (h), as
well as in vessels (v), and caudal vein plexus (CVP) of the trunk. c' is an
enlargement of C. d, e Cross sections of embryos from c’ show that
nr2f1b is expressed in dorsal aorta (da), posterior cardinal vein (pcv), and
caudal vein plexus (CVP). Scale bars in all figures represent 100 μm.
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arterial fate. Instead, we observed slightly decreased num-
ber of cells contributing to the DA in the same region
(67.5 ± 7.3 cells in wt and 57.9 ± 8.3 cells, p < 0.01),
however, overexpression of nr2f1b did not increase
the arterial cells (69.1 ± 10.9 cells, n = 10, p = 0.68),
suggesting the minor necessary role of nr2f1b in aorta
differentiation (data not shown).
To determine if loss of nr2f1b results in altered ex-
pression of arterial and venous markers, we examined
the expression flt4, mrc1, notch3, and ephrinb2 by ISH
in nr2f1b morphants. No obvious differences in the ex-
pression of the arterial markers notch3 and ephrinb2
were observed in nr2f1b morphants compared to con-
trols at 24 hpf by both lateral view (Fig. 3i-l) and cross-
section images (Fig. 3i’-l’). Conversely, expression of the
venous markers flt4 and mrc1 was diminished in nr2f1b
morphants compared to wild type controls at 24 hpf by
both lateral view (Fig. 3e-h) and cross-section images
(Fig. 3e’-h’). To determine the extent of decreased
marker expression, we quantified flt4 and ephrinb2 tran-
script levels by qPCR and identified a 60 % decrease in
flt4 expression but no change in ephrinb2 expression in
nr2f1b morphants (Fig. 3d). These results suggest that
the decrease in venous markers expression most likely
due to a decreased number of vein cells.
To test whether excess nr2f1b might increase the number
of cells contributing to the PCV, we over-expressed nr2f1b
under control of the fli1a promoter. Overexpression of
nr2f1b in transient transgenic embryos has a slight but
significant increase on PCV cell number (100.3 ± 17.7 cells,
n = 10) compared to uninjected controls (82.5 ± 11.5 cell;
p < 0.01 by student t-test) (Fig. 4a-c). Taken all together, the
our data suggests that nr2f1b has a role in venous endothe-
lial cell specification as loss and over-expression of nr2f1b
results in decreased and increased numbers of endothelial
cells contributing to the PCV, respectively.
nr2f1b modulates the number and migration of
angioblasts in intersegmental vessels
The number of cells comprising the trunk intersegmen-
tal vessels is regulated by a number of pathways where
reduced numbers of cells per ISV can result in ISV
growth defect. To determine if a reduced number of
cells was present in stalled ISVs, the number of cells per
ISV was assessed after knockdown of nr2f1b in Tg(fli1a:-
negfp)y7 or Tg (kdrl:mCherryci5; fli1a:negfp y7) embryos
(Fig. 5a-b and Fig. 2h-i). We observed a reduced ISV
cells in nr2f1b morphants compared to wild-type control
(Fig. 2j) and the distribution of ISV cells showed at less
cells area in nr2f1b MO as compared to uninjected
Fig. 2 Morpholino knockdown of nr2f1b causes defects in vascular development. a In uninjected control embryos, the arota (da) and posterior
cardinal vein (pcv) have formed by 30 hpf and intersegmental vessels (isv) have reached the DLAV at the dorsal aspect of the embryo. At the
same stage ISVs are stalled mid-somite in nr2f1bi1e2 (b), nr2f1be1i1 (e) and nr2f1bATG (f) morphants. Overexpression of nr2f1b has no obvious
defect in vasculature (d), but rescues the defect of ISV stalling (solid arrowhead) as shown in (c). g Quantification of percentage of completed ISV
shows a 40 % increase compare to nr2f1b morphants (*** refers to p < 0.0001 by an unpaired student's t-test. Scale bars are 50 μm for (a-f).
h and i Imaging of endothelial nuclei in green and vessels in red at 30 hpf in wild-type control and nr2f1b MO-treated embryos using Tg(fli1a:-
nEGFP)y7:(kdrl:mCherry)ci5 double transgenic line. nr2f1b morphants showed reduced ISV nuclei numbers (i). j Quantification of ISV nuclei number
in nr2f1b morphants (n = 18) compared to wild-type control (n = 16). ***P < 0.001, Student t test.
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embryos (Fig. 3c). Moreover, endothelial-specific over-
expression of nr2f1b using the fli1 promoter results in
an increased average number of cells per ISV (4.3 ± 0.9;
n = 88 ISVs) in transient transgenic embryos compared
to 3.8 ± 0.7 cells (n = 86 ISVs) in wild type (p <
0.0005) (Fig. 4d-f ). These data suggest that nr2f1b is ne-
cessary and sufficient to promote a tip cell identity for
ISV growth.
To examine whether migration of ISV angioblasts is
deficient, time-lapse imaging was performed in wild type
Tg(kdrl:eGFP) la116 and nr2f1b knockdown embryos.
Superimposition of images of 23hpf embryo (red) on the
same embryo at 26hpf (green) shows an average of an
over 50 % decreased area of extension/migration of ISVs
in nr2f1b morphants as compared to wild type embryos
(Fig. 5d-j). The decrease in extension could represent
decreased protrusive activity of angioblasts, or could
result from fewer angioblasts migrating. We therefore
examined ISV cell number in Tg(fli1a:neGFP)y7 trans-
genic embryos on these time-lapse images. We found
cells showed slower migration and ISVs that eventually
migrate to the DLAV in nr2f1b morphants have fewer
cells per ISV (Fig. 5k-p) than wild type, suggesting that
nr2f1b regulates the number of cells in an ISV and the
migration of ISV. Together, these data suggest that
nr2f1b modulates the number and migration of angio-
blasts during ISV growth.
Interaction between nr2f1b and Notch signaling
We have demonstrated that knockdown of nr2f1b ex-
pression by morphlino injection results in ISV stalling at
the midline with a decrease in the number of cells per
ISV, while over-expression of nr2f1b leads to an in-
creased number of cells per ISV. These observations are
Fig. 3 Nr2f1b modulates vein cell number and marker expression. a-c At 30 hpf, loss of nr2f1b function in Tg(fli1a:negfp)y7 embryos results in
reduced vein cell number (b, blue bracket) as compared to uninjected wild type controls (a). The artery is marked by a red bracket. c Quantitative
analysis shows a significant reduction in vein cell number in nr2f1b morphants. Compared to wild type controls. e, g, i, k, expression of the
venous markers flt4 (f) and mrc1 (g) is reduced in the trunk of nr2f1b morphants at 24 hpf while there is no obvious change in the expression of
arterial markers notch3 (i) and ephrinb2 (k). e’-l’ are cross sections of embryos in (e-l). d Quantification by qPCR shows a 60 % reduction in flt4
expression but no change in ephrinb2 expression in nr2f1b morphants (***refers to p < 0.0001 and **refers to p < 0.001 by an unpaired student's
t-test. Scale bars represent 50 μm in a, b, e-l and scare bar in cross-sections e’-l’ is 30 μm). Abbreviations: posterior cardinal vein (pcv), dorsal aorta
(da), neural tube (nt) and pronephric ducts (pd).
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qualitatively similar to those seen with modulation of
Notch signaling where activation of Notch signaling
gives ISV stalling at the midline, while loss of notch sig-
naling leads to an increased number of cells per ISV
(Siekmann 2007). Thus, we sought to determine if Notch
regulates nr2f1b expression. Notch signaling involves
two sequential proteolytic processing events (ADAM
protease and γ-secretase) that release the Notch intracel-
lular domain (NICD) into cytoplasm followed by trans-
location to the nucleus where it interacts with the
transcription factor rbpsuh (recombination binding protein/
suppressor of hairless) to activation of target genes. DAPT
specifically inhibit γ -secretase involved in the cleavage of
NICD and prevents Noch activation. Therefore, to test if
nr2f1b interacts with Notch signaling, we suppressed Notch
signaling by rbpsuhMO injection (Fig. 6a-c) or DAPT treat-
ment (Fig. 6d-f). We found nr2f1b expression is upregu-
lated when Notch signals were inhibited, with a 2-2.5 fold
increase by using in-situ hybridization and qPCR (Fig. 6).
These results suggest that nr2f1b might act downstream of
Notch signals. We next asked whether nr2f1b and Notch
genetically interact to control ISV growth. To test this, we
performed a rescue experiment by injecting nr2f1b morpho-
lino in an rbpsuh morphants (rbpsuhMO). Wild type em-
bryos at 30 hpf have an average of 3.6 ± 0.6 cells per ISV
(Fig. 6g, k). nr2f1b morphants have an average of 1.7 ± 0.7
cells per ISV, while rbpsuh morphants have an average of
6.2 ± 1.6 cells per ISV (Fig. 6h, i, k). Knockdown of rbpsuh
in combined with nr2f1b morpholino injection reduces
the number of cells per ISV to wild type levels 3.8 ± 1.2
(Fig. 6j, K; n = 25 ISV from 4 fish; p = 0.56, unpaired
student t-test). Together, these data suggest nr2f1b likely
acts downstream of Notch signaling and antagonizes
Notch signals to control ISV growth.
Discussion
nr2f1b expressed in developing vessels functioning in
vasculature
In this study, we observed the expression of nr2f1b in lateral
plate mesoderm at early stage and developing vessels (Fig. 1)
corresponding to the location in which primitive angioblasts
are developing and acquiring arterial and venous identity.
At 24hpf, the expression pattern of nr2f1b continues in the
vasculature, suggested the role of nr2f1b in vascular devel-
opment. We further have shown that knockdown of nr2f1b
results in vascular defects, including ISV growth impair-
ment, pericardial edema, less venous cells and results in loss
of circulation (Fig. 2 and Additional file 1: Figure S3). In
fact, there is no parachorda vessel (PCV, pre-structure of
lymphatic duct) formation and defects in caudal vessel
plexus (CVP) (data not shown) suggested that the impair-
ment of venous angiogenesis at late developmental stage,
which is likely the later effects of loss of nr2f1b.
nr2f1b functions in vein identity and the growth of
intersegmental vessels
Here, we explored the function of nr2f1b modulates vein
identity. We showed the decrease of endothelial venous
cells and the expression of venous markers flt4 and mrc1;
however, there is no obvious change in the expression of
arterial markers notch3 and ephrinb2 (Fig. 3) although
there is a slight decrease of arterial cells. This suggested
Fig. 4 Overexpression of Nr2f1b under the fli promoter increases the number of venous cells and endothelial cells per ISV. a-b The number of
vein cells was counted in the region beneath ISV 5-15 from 14 wild type or 10 Tg(fli1a:nr2f1b) transient transgenic, overexpressing embryos. The
artery is marked by a red bracket, and the vein by a blue bracket. c Uninjected control embryos have 82.5 (± 11.5) cells per vein segment while
fli:nr2f1b over-expressing embryos had 100.3 (± 17.7) cells (p = 0.0068; unpaired t-test). d-f The number of cells forming each ISV were determined
in wild type control (d) and fli1a: nr2f1b overexpressing embryos (e) at 30 hpf. f The average cells of wild type control is 3.8 ± 0.7 (ISV n = 86) and
the average cells of fli:nr2f1b over-expressing embryos is 4.3 ± 0.9 (ISV n = 88). ***refers to p < 0.0005 by an unpaired student's t-test and graphic
error bars represent 1 SEM.. Scale bars in a, b, d, e represent 50 μm.
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that nr2f1b is not involved in artery-vein fate switching.
Thus, the reduction in cell number and the loss of vein
marker expression together suggest that nr2f1b is neces-
sary for normal vein development. We also showed that
overexpression of nr2f1b has a slight but significant in-
crease on PCV cell number (Fig. 4). Together, those data
suggest the role of nr2f1b is necessary and sufficient for
vein development.
Intersegmental vessels form from angioblasts sprouting
from the dorsal aorta and vein. Stalling of intersegmental
vessel growth at the mid somite might therefore either
occur through defective proliferation or defective
Fig. 5 Nr2f1b is required for the growth of intersegmental vessels. The number of cells forming each ISV were counted in wild type control
Tg(fli1a:negfp)y7 (a) and nr2f1b morphant embryos (b) at 30 hpf. c Proportional distribution of ISVs containing 1-7 cells in both conditions.
d-j Time-lapse imaging of wild type Tg(kdrl:eGFP) la116 (d-f) and nr2f1b morphant (g-i) embryos to examine the extension of ISV tip cell filopodia.
Confocal images at 23 hpf (red; d, g) and 26hpf (green; e, h) were merged (f, i). The extension of tip cell was quantitated by pixel intensity and
shows reduced extension of tip cell in nr2f1bMO (j). k-p Time-lapse imaging of wild type Tg(fli1a:nEGFP) y7 (k-m) and nr2f1b morphant (n-p).
Scale bars represent 50 μm.
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migration of cells. Here, we showed in nr2f1b morphants
contains less cells compared to in wild-type (Fig. 5). We
also showed a significant increase in ISV cell numbers
suggesting that nr2f1b is necessary and sufficient to pro-
mote a proliferation of ISV cells. Further examining the
migration of ISV angioblasts in nr2f1b knockdown
Tg(fli1a:eGFP)y1 and Tg(fli1a:neGFP)y7embryos, we
showed that the decrease in extension represent the de-
creased protrusive activity of angioblasts and fewer angio-
blasts in migrating (Fig. 5), suggesting that nr2f1b
regulates the number of cells in an ISV and the migration
of ISV. Loss of nr2f1b in zebrafish leads to decreased
numbers of cells in the posterior cardinal vein and in ISVs,
but the ultimate fate of these cells remains unknown.
TUNEL analysis suggests that cell death is not increased
in the trunk region and we did not observe additional cells
contributing to the artery or ISVs. This suggests there may
be a lack of proliferation of venous precursors or these
cells may adopt a closely related fate in the mesoderm
lineage, such as blood.
Interaction between nr2f1b, nr2f2 and isl2 in regulating
vein identity and ISV growth?
We previous identified isl2 promotes vein and tip cell
identity (paper under revision) and nr2f2 also plays
minor role on that although NR2F2 is a major determin-
ant of venous identity in mouse. In this study, we
showed that zebrafish Nr2f1b ortholog to mouse NR2F2
plays a major role in vein and tip cell identity. It has
been shown that LIM-homeodimer transcription factor
isl1 (an ortholog of Isl2) and CoupTFI physically bind
together in vitro and in vivo to activate transcription
[38], suggesting the possible interaction between isl2 and
nr2f1b to control vascular development. Thus, whether
Nr2f1b/Nr2f2 and Isl2 also physically interact at the pro-
tein level to activate target genes and regulate endothelial
cell identity remains an interesting avenue to explore in the
future. Meanwhile, it would be also intriguing to address if
any other signaling molecules in addition to notch, such as
vegf, wnt or BMP etc. that interact with nr2f1b and/or isl2.
The molecular mechanisms that how nr2f1b regulate its
Fig. 6 The expression of Nr2f1b is upregulated by notch signaling. a, b nr2f1b expression is increased at 24 hpf embryos after treatment with
DAPT as compared to DMSO control embryos by in situ hybridization. d, e nr2f1b expression is upregulated in rbpsuh morphants at 24 hpf
embryos. c, f Quantification by qPCR showed the increased expression of nr2f1b in rbpsuh morphants or DAPT treated embryos at 24 hpf
significantly. g-j Representative confocal images showing the number of nuclei per ISV at 30 hpf in g wild-type (wt) embryos, h nr2f1bMO, i
rbpsuhMO, and j rbpsuhMO with nr2f1bMO. k Quantitation of the average number of cells per ISV in single and double morphants. ***refers to
p < 0.0005 by an unpaired student's t-test. Scale bars represent 100 μm in a, b, d, e and 50 μm in g-j.
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targets in vascular development is still unknown and we
are currently addressing this question by processing and
analyzing genome-wide transcriptome results.
Does zebrafish Nr2f1b play a conserved role in
vasculature similar to nr2f2 in mice?
Swift’s study showed SoxF factors and Notch regulate
nr2f2 gene expression during venous differentiation [12]
and Aranguren et al showed coupTFII functions in ven-
ous and lymphatic development in both zebrafish and
Xenopus [11]. However, knockdown nr2f2 in both stud-
ies did not see obvious defects in vascular development,
but reduction of venous gene expression, suggest nr2f2
control venous differentiation, instead of specification.
In this study, we showed that zebrafish Nr2f1b ortholog
to mouse Nr2f2 and plays a major role in vein and tip
cell identity, which is consistent with the function of
nr2f2 in mice [9]. Those data indicate that the conserved
vascular function of coupTF family among the verte-
brates. Phylogenetic analysis of coupTFs amino acids
among the vertebrates suggests that zebrafish nr2f1b
and nr2f2 are very closer to mammalian nr2f2 (over 83 %
identical). It would be intriguing to address if any func-
tional rescue or compensation between zebrafish nr2f1b
and mouse nr2f2.
Conclusions
In summary, our study demonstrated that nr2f1b has a crit-
ical role in blood vessel formation in zebrafish. We showed
that loss of nr2f1b reduced venous cells and the expression
of vein specific markers. We also showed that nr2f1b mor-
phant reduces ISV cells and impairs ISV growth. While
overexpression of nr2f1b increase vein and ISV cells, sug-
gesting that nr2f1b play a role in promoting vein and tip
cell identity. We further showed that nr2f1b functions in
vascular development in concert with Notch signalling.
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